Cargando…

Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia

Progressive age is the single major risk factor for neurodegenerative diseases. Cellular aging markers during Parkinson’s disease (PD) have been implicated in previous studies, however the majority of studies have investigated the association of individual cellular aging hallmarks with PD but not jo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asghar, Muhammad, Odeh, Amani, Fattahi, Ahmad Jouni, Henriksson, Alexandra Edwards, Miglar, Aurelie, Khosousi, Shervin, Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584960/ https://www.ncbi.nlm.nih.gov/pubmed/36266468 http://dx.doi.org/10.1038/s41598-022-22400-z

Ejemplares similares

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Impaired migratory phenotype of CD4(+) T cells in Parkinson’s disease
por: Mamula, Dejan, et al.
Publicado: (2022)

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
por: Paslawski, Wojciech, et al.
Publicado: (2023)

The Length of the Shortest Telomere as the Major Determinant of the Onset of Replicative Senescence
por: Xu, Zhou, et al.
Publicado: (2013)

Effects of initial telomere length distribution on senescence onset and heterogeneity
por: Eugène, Sarah, et al.
Publicado: (2017)

Components of the ribosome biogenesis pathway underlie establishment of telomere length set point in Arabidopsis
por: Abdulkina, Liliia R., et al.
Publicado: (2019)

Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence
por: Anderson, Rhys, et al.
Publicado: (2019)

Telomere Length Shortening in Microglia: Implication for Accelerated Senescence and Neurocognitive Deficits in HIV
por: Hsiao, Chiu-Bin, et al.
Publicado: (2021)

Changes in telomere length and senescence markers during human ovarian tissue cryopreservation
por: Kim, Boram, et al.
Publicado: (2021)

Is sperm telomere length altered in teratozoospermia specimens? A case-control study
por: Fattahi, Maryam, et al.
Publicado: (2023)

Impacts of Telomeric Length, Chronic Hypoxia, Senescence, and Senescence-Associated Secretory Phenotype on the Development of Thoracic Aortic Aneurysm
por: Aschacher, Thomas, et al.
Publicado: (2022)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

microRNA biogenesis and senescence
por: Gómez-Cabello, Daniel, et al.
Publicado: (2013)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer
por: Yoon, Jung Hwan, et al.
Publicado: (2014)

The Individual Blood Cell Telomere Attrition Rate Is Telomere Length Dependent
por: Nordfjäll, Katarina, et al.
Publicado: (2009)

Newborn telomere length predicts later life telomere length: Tracking telomere length from birth to child- and adulthood
por: Martens, Dries S., et al.
Publicado: (2021)

Seryl tRNA synthetase cooperates with POT1 to regulate telomere length and cellular senescence
por: Li, Yingxi, et al.
Publicado: (2019)

A proteomic signature for dementia with Lewy bodies
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Telomeres and Telomere Length: A General Overview
por: Srinivas, Nalini, et al.
Publicado: (2020)

Telomere Length Regulation
por: Lansdorp, Peter
Publicado: (2022)

Telomere length heterogeneity in placenta revealed with high-resolution telomere length analysis
por: Garcia-Martin, I., et al.
Publicado: (2017)

Leucocyte telomere length, brain volume and risk of dementia: a prospective cohort study
por: Cao, Zhi, et al.
Publicado: (2023)

TFEB‐dependent lysosome biogenesis is required for senescence
por: Curnock, Rachel, et al.
Publicado: (2023)

Biomarkers of cellular aging during a controlled human malaria infection
por: Miglar, Aurelie, et al.
Publicado: (2021)

Telomeres and Cell Senescence - Size Matters Not
por: Victorelli, Stella, et al.
Publicado: (2017)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Spatial Perseveration in Dementia with Lewy Bodies
por: Assal, Frédéric, et al.
Publicado: (2007)

Clinical diagnosis of Lewy body dementia
por: Surendranathan, Ajenthan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nvbjlgb7os6ia0pjom2400tk60